Hemogram-derived ratios as prognostic markers for major adverse cardiovascular events in patients with non-ST-segment elevation myocardial infarction

Table 2 Primary hematological and inflammatory parameters in studied groups, median (25^th-75^th percentiles)

Parameter	Time	MACE (n = 86)	Control (n = 84)	P value
Leukocytes	T1	9.9 (7.9-11.9)	9.3 (7.4-11.8)	0.322
	T2	9.1 (7.3-11.3)	8.9 (6.7-10.6)	0.264
Erythrocytes	T1	4.5 (4.1-5.0)	4.3 (3.9-4.8)	0.078
	T2	4.5 (4.0-4.9)	4.4 (4.0-4.9)	0.581
Platelets	T1	238.5 (187.0-286.0)	220.0 (176.5-253.5)	0.056
	T2	240.0 (174.0-283.0)	216.5 (180.0-257.0)	0.287
Monocytes	T1	0.7 (0.5-0.9)	0.7 (0.5-0.9)	0.344
	T2	0.7 (0.6-1.0)	0.8 (0.6-0.9)	0.882
Basophils	T1	0.0 (0.0-0.0)	0.0 (0.0-0.1)	0.563
	T2	0.0 (0.0-0.0)	0.0 (0.0-0.1)	0.403
Eosinophils	T1	0.0 (0.0-0.1)	0.1 (0.0-0.1)	0.111
	T2	0.0 (0.0-0.1)	0.1 (0.0-0.2)	0.321
Lymphocytes	T1	1.6 (1.1-2.1)	1.5 (1.2-2.0)	0.130
	T2	1.7 (1.2-2.3)	1.8 (1.2-2.3)	0.090
Neutrophils	T1	7.3 (5.6-9.0)	6.4 (4.7-9.8)	0.611
	T2	6.2 (4.9-8.7)	5.8 (4.2-7.5)	0.374
C-reactive protein	T1	7.4 (2.6-30.4)	8.9 (2.2-21.5)	0.215
	T2	30.5 (6.3-67.7)	13.4 (5.0-48.5)	0.051

MACE: Major adverse cardiovascular event.